Real-world assessment of ipilimumab plus nivolumab in anti-PD-L1/PD-1-refractory Merkel Cell Carcinoma

Shalhout, SZ; Emerick, KS; Kaufman, HL; Miller, DM

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022; 142 (10): 2840